NewAmsterdam Pharma Corporation Email Formats
Biotechnology Research • 
Aventura, Florida, United States • 51-100 Employees
NewAmsterdam Pharma Corporation Email Formats
NewAmsterdam Pharma Corporation uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@newamsterdampharma.com), used 62.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@newamsterdampharma.com | 62.5% |
{first name}.{last name} | john.doe@newamsterdampharma.com | 36.1% |
{first initial}.{second initial}{last name} | j.odoe@newamsterdampharma.com | 1.4% |
Key Contacts at NewAmsterdam Pharma Corporation
Adele Gulfo
Independent Director
Allen Che
Senior Director, Drug Substance Development & Manufacturing
Will Lewis
Chair Of The Board Of Directors
Charles Perez
Senior Director, It Security & Compliance
Christian Wichterman
Executive Director, Hcp Marketing & Strategy
Siddharth Agrawal
Sr. Director - Strategy
Matthew Wagener
Senior Director Of Finance Operations
Thomas Cala
Executive Director Information Technology
Cassi O'Neil
Senior Director, Consumer And Omnichannel Marketing
Guilong Charles Cheng
Senior Director Of Analytical Development
Company overview
| Headquarters | Aventura, Florida, United States |
| Phone number | +1310352062971 |
| Website | |
| Founded | 2019 |
| Employees | 51-100 |
| Socials |
About NewAmsterdam Pharma Corporation
This page is intended for US audiences. Founded in 2019, NewAmsterdam Pharma Corporation is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies have been unsuccessful or are not tolerated. The Company is investigating a selective cholesteryl ester transfer protein (CETP) inhibitor as an LDL-C lowering therapy for patients who cannot be treated optimally with currently available lipid-lowering therapy or for patients with Atherosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally tolerated statin therapy.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
NewAmsterdam Pharma Corporation has 41 employees across 9 departments.
Departments
Number of employees
Funding Data
Explore NewAmsterdam Pharma Corporation's funding history, including investment rounds, total capital raised, and key backers.
NewAmsterdam Pharma Corporation Tech Stack
Discover the technologies and tools that power NewAmsterdam Pharma Corporation's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
JavaScript libraries
Maps
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Webmail
Miscellaneous
Security
United Kingdom
Canada
Germany
Frequently asked questions
4.8
40,000 users
